|
Document - Document and Entity Information |
Document - Document and Entity Information (USD $) |
3 Months Ended |
|
( custom:DocumentAndEntityInformationAbstract [Extension] ) |
|
|
|
Mar. 31, 2015 |
May. 12, 2015 |
|
|
|
|
|
|
|
|
|
Entity Registrant Name |
Artventive Medical Group, Inc. | |
| |
( dei:EntityRegistrantName ) |
| |
| |
Entity Central Index Key |
0001405249 | |
| |
( dei:EntityCentralIndexKey ) |
| |
| |
Document Type |
10-Q | |
| |
( dei:DocumentType ) |
| |
| |
Document Period End Date |
2015-03-31 | |
| |
( dei:DocumentPeriodEndDate ) |
| |
| |
Amendment Flag |
false | |
| |
( dei:AmendmentFlag ) |
| |
| |
Current Fiscal Year End Date |
--12-31 | |
| |
( dei:CurrentFiscalYearEndDate ) |
| |
| |
Is Entity a Well-known Seasoned Issuer? |
No | |
| |
( dei:EntityWellKnownSeasonedIssuer ) |
| |
| |
Is Entity a Voluntary Filer? |
No | |
| |
( dei:EntityVoluntaryFilers ) |
| |
| |
Is Entity's Reporting Status Current? |
Yes | |
| |
( dei:EntityCurrentReportingStatus ) |
| |
| |
Entity Filer Category |
Smaller Reporting Company | |
| |
( dei:EntityFilerCategory ) |
| |
| |
Entity Public Float |
| |
| |
( dei:EntityPublicFloat ) |
| |
| |
Entity Common Stock, Shares Outstanding |
| |
60,406,286 | |
( dei:EntityCommonStockSharesOutstanding ) |
| |
| |
Document Fiscal Period Focus |
Q1 | |
| |
( dei:DocumentFiscalPeriodFocus ) |
| |
| |
Document Fiscal Year Focus |
2015 | |
| |
( dei:DocumentFiscalYearFocus ) |
| |
| |
|
(End Document - Document and Entity Information) |
|
Statement - Balance Sheets (Unaudited) |
Statement - Balance Sheets (Unaudited) (USD $) |
|
|
( us-gaap:StatementOfFinancialPositionAbstract ) |
|
|
|
Mar. 31, 2015 |
Dec. 31, 2014 |
|
|
|
|
|
|
|
|
|
|
| |
| |
|
| |
| |
Assets |
| |
| |
( us-gaap:AssetsAbstract ) |
| |
| |
current |
| |
| |
( us-gaap:AssetsCurrentAbstract ) |
| |
| |
Cash and cash equivalents |
80,480 | |
104,030 | |
( us-gaap:CashAndCashEquivalentsAtCarryingValue ) |
| |
| |
Accounts receivable |
22,610 | |
22,662 | |
( us-gaap:AccountsReceivableNet ) |
| |
| |
Prepaid expenses |
1,048 | |
1,048 | |
( us-gaap:PrepaidExpenseCurrent ) |
| |
| |
Inventory |
61,687 | |
23,738 | |
( us-gaap:InventoryGross ) |
| |
| |
Total current assets |
165,825 | |
151,478 | |
( us-gaap:AssetsCurrent ) |
| |
| |
PROPERTY, PLANT and equipment |
| |
| |
( us-gaap:PropertyPlantAndEquipmentAbstract ) |
| |
| |
Office equipment |
20,893 | |
17,953 | |
( us-gaap:PropertyPlantAndEquipmentOther ) |
| |
| |
Accumulated depreciation |
(6,397 | ) |
(5,467 | ) |
( us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment ) |
| |
| |
net property, plant and equipment |
14,496 | |
12,486 | |
( us-gaap:PropertyPlantAndEquipmentNet ) |
| |
| |
other assets |
| |
| |
( us-gaap:OtherAssetsAbstract ) |
| |
| |
Deposits |
28,869 | |
25,007 | |
( us-gaap:Deposits ) |
| |
| |
total other assets |
28,869 | |
25,007 | |
( us-gaap:OtherAssets ) |
| |
| |
|
| |
| |
|
| |
| |
Total assets |
209,190 | |
188,971 | |
( us-gaap:Assets ) |
| |
| |
|
| |
| |
|
| |
| |
Liabilities and stockholders EQUITY |
| |
| |
( us-gaap:LiabilitiesAndStockholdersEquityAbstract ) |
| |
| |
current LIABILITES |
| |
| |
( us-gaap:LiabilitiesCurrentAbstract ) |
| |
| |
Accounts payable |
483,522 | |
221,397 | |
( us-gaap:AccountsPayableCurrent ) |
| |
| |
Accrued expenses |
1,070,800 | |
1,043,300 | |
( us-gaap:AccruedLiabilitiesCurrent ) |
| |
| |
Payroll taxes payable |
61 | |
— | |
( us-gaap:AccruedPayrollTaxesCurrent ) |
| |
| |
Total CURRENT liabilities |
1,554,383 | |
1,264,697 | |
( us-gaap:LiabilitiesCurrent ) |
| |
| |
|
| |
| |
|
| |
| |
LONG-TERM LIABILITES |
| |
| |
( us-gaap:LongTermDebtAbstract ) |
| |
| |
Notes payable |
500,000 | |
500,000 | |
( us-gaap:NotesPayable ) |
| |
| |
Total LONG-TERM liabilities |
500,000 | |
500,000 | |
( us-gaap:LongTermDebtNoncurrent ) |
| |
| |
|
| |
| |
|
| |
| |
Total LIABILITIES |
2,054,383 | |
1,764,697 | |
( us-gaap:AccruedLiabilitiesCurrentAndNoncurrent ) |
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
stockholders EQUITY (deficit) |
| |
| |
( us-gaap:EquityAbstract ) |
| |
| |
|
| |
| |
|
| |
| |
Common stock, par value $.001, 100,000,000 shares authorized, 60,156,286 and 59,506,286 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively |
60,156 | |
59,506 | |
( us-gaap:CommonStockParOrStatedValuePerShare ) |
| |
| |
Additional paid in capital |
13,498,047 | |
12,879,982 | |
( us-gaap:AdditionalPaidInCapital ) |
| |
| |
Retained deficit |
(15,403,396 | ) |
(14,515,214 | ) |
( us-gaap:RetainedEarningsAccumulatedDeficit ) |
| |
| |
TOTAL STOCKHOLDERS EQUITY (DEFICIT) |
(1,845,193 | ) |
(1,575,726 | ) |
( us-gaap:StockholdersEquity ) |
| |
| |
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT) |
209,190 | |
188,971 | |
( us-gaap:LiabilitiesAndStockholdersEquity ) |
| |
| |
|
(End Statement - Balance Sheets (Unaudited)) |
|
Statement - Balance Sheets (Parenthetical) |
Statement - Balance Sheets (Parenthetical) (USD $) |
|
|
( us-gaap:StatementOfFinancialPositionAbstract ) |
|
|
|
Mar. 31, 2015 |
Dec. 31, 2014 |
|
|
|
|
|
|
|
|
|
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
Common stock, par value $.001, shares authorized |
100,000,000 | |
100,000,000 | |
( us-gaap:CommonStockSharesAuthorized ) |
| |
| |
Common stock, par value $.001, shares issued and outstanding |
60,156,286 | |
59,506,286 | |
( us-gaap:CommonStockSharesIssued ) |
| |
| |
|
(End Statement - Balance Sheets (Parenthetical)) |
|
Statement - Statements of Operations (Unaudited) |
Statement - Statements of Operations (Unaudited) (USD $) |
3 Months Ended |
( us-gaap:IncomeStatementAbstract ) |
|
|
Mar. 31, 2015 |
Mar. 31, 2014 |
|
|
|
|
|
|
|
|
|
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
revenues |
64,187 | |
10,165 | |
( us-gaap:Revenues ) |
| |
| |
COST OF GOODS SOLD |
64,187 | |
10,165 | |
( us-gaap:CostOfGoodsSold ) |
| |
| |
GROSS PROFIT |
— | |
— | |
( us-gaap:GrossProfit ) |
| |
| |
|
| |
| |
|
| |
| |
operating expenses |
| |
| |
( us-gaap:OperatingExpensesAbstract ) |
| |
| |
Exploration costs |
— | |
— | |
( us-gaap:ExplorationCosts ) |
| |
| |
Research and development |
301,926 | |
289,522 | |
( us-gaap:ResearchAndDevelopmentExpense ) |
| |
| |
Selling, general and administrative |
585,327 | |
1,466,676 | |
( us-gaap:SellingGeneralAndAdministrativeExpense ) |
| |
| |
Depreciation expense |
930 | |
771 | |
( us-gaap:Depreciation ) |
| |
| |
TOTAL operating expenses |
(888,183 | ) |
(1,756,969 | ) |
( us-gaap:OperatingExpenses ) |
| |
| |
|
| |
| |
|
| |
| |
Operating loss before other items and income tax |
(888,183 | ) |
(1,756,969 | ) |
( us-gaap:OperatingIncomeLoss ) |
| |
| |
Other INCOME/(EXPENSE) |
| |
| |
( us-gaap:OtherOperatingIncomeExpenseNet ) |
| |
| |
Interest income |
1 | |
477 | |
( us-gaap:InterestAndDividendIncomeOperating ) |
| |
| |
Income taxes |
— | |
— | |
( us-gaap:IncomeTaxesPaid ) |
| |
| |
net loss availAble to common stockholders |
(888,182 | ) |
(1,756,492 | ) |
( us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic ) |
| |
| |
COMPREHENSIVE LOSS FOR THE PERIOD |
(888,182 | ) |
(1,756,492 | ) |
( us-gaap:ComprehensiveIncomeNetOfTax ) |
| |
| |
basic and diluted loss per common share |
0 | |
0 | |
( us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare ) |
| |
| |
weighted average shares outstanding |
59,765,175 | |
56,022,953 | |
( us-gaap:WeightedAverageBasicSharesOutstandingProForma ) |
| |
| |
|
(End Statement - Statements of Operations (Unaudited)) |
|
Statement - Statements of Cash Flows (Unaudited) |
Statement - Statements of Cash Flows (Unaudited) (USD $) |
3 Months Ended |
( us-gaap:StatementOfCashFlowsAbstract ) |
|
|
Mar. 31, 2015 |
Mar. 31, 2014 |
|
|
|
|
|
|
|
|
|
|
| |
| |
|
| |
| |
|
| |
| |
|
| |
| |
cash flow from operating activities |
| |
| |
( us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract ) |
| |
| |
Net loss |
(888,182 | ) |
(1,756,492 | ) |
( us-gaap:NetIncomeLoss ) |
| |
| |
Adjustments to reconcile net loss to net cash used by operating activities |
| |
| |
( us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract ) |
| |
| |
|
| |
| |
|
| |
| |
Non-cash expenses |
33,715 | |
— | |
( us-gaap:OtherNoncashIncomeExpense ) |
| |
| |
Depreciation expense |
930 | |
771 | |
( us-gaap:DepreciationAndAmortization ) |
| |
| |
|
| |
| |
|
| |
| |
Changes IN operating assets and liabilities |
| |
| |
( us-gaap:IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract ) |
| |
| |
Accounts receivable |
52 | |
(10,165 | ) |
( us-gaap:IncreaseDecreaseInAccountsReceivable ) |
| |
| |
Prepaid expenses |
— | |
8,050 | |
( us-gaap:IncreaseDecreaseInPrepaidExpense ) |
| |
| |
Inventory |
(37,949 | ) |
(253,242 | ) |
( us-gaap:IncreaseDecreaseInInventories ) |
| |
| |
Deposits |
(3,862 | ) |
— | |
( us-gaap:IncreaseDecreaseInDeposits ) |
| |
| |
Accounts payable |
262,125 | |
(127,825 | ) |
( us-gaap:IncreaseDecreaseInAccountsPayable ) |
| |
| |
Payroll taxes payable |
61 | |
— | |
( us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities ) |
| |
| |
Accrued expenses |
(37,500 | ) |
— | |
( us-gaap:IncreaseDecreaseInAccruedLiabilities ) |
| |
| |
Net cash used by operating activities |
(670,610 | ) |
(2,138,903 | ) |
( us-gaap:NetCashProvidedByUsedInContinuingOperations ) |
| |
| |
cash flows from investing activities |
| |
| |
( us-gaap:NetCashProvidedByUsedInInvestingActivitiesAbstract ) |
| |
| |
Purchase of equipment |
(2,940 | ) |
— | |
( us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ) |
| |
| |
NET CASH used BY INVESTING ACTIVITIES |
(2,940 | ) |
— | |
( us-gaap:NetCashProvidedByUsedInInvestingActivities ) |
| |
| |
cash flows from financing activities |
| |
| |
( us-gaap:NetCashProvidedByUsedInFinancingActivitiesAbstract ) |
| |
| |
Issuance of common stock for cash |
650,000 | |
1,100,000 | |
( us-gaap:ProceedsFromIssuanceOrSaleOfEquity ) |
| |
| |
Issuance of notes payable |
— | |
500,000 | |
( us-gaap:ProceedsFromNotesPayable ) |
| |
| |
Convertible note payable (see Note 4) |
— | |
— | |
( us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature ) |
| |
| |
NET CASH PROVIDED BY FINANCING ACTIVITIES |
650,000 | |
1,600,000 | |
( us-gaap:NetCashProvidedByUsedInFinancingActivities ) |
| |
| |
net increase (decrease) in cash and cash equivalents |
(23,550 | ) |
(538,903 | ) |
( us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease ) |
| |
| |
|
| |
| |
|
| |
| |
cash, beginning of period |
104,030 | |
1,626,521 | |
( us-gaap:Cash ) |
| |
| |
cash, end of period |
80,480 | |
1,087,618 | |
( us-gaap:Cash ) |
| |
| |
|
| |
| |
|
| |
| |
non-cash investing and financing activities |
| |
| |
( us-gaap:NoncashInvestingAndFinancingItemsAbstract ) |
| |
| |
sTOCK ISSUED UPON CONVERSION OF NOTE PAYABLE |
— | |
— | |
( us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities ) |
| |
| |
forgiveness OF RELATED PARTY NOTE; APPLIED TO PAID IN CAPITAL |
— | |
— | |
( us-gaap:RepaymentsOfRelatedPartyDebt ) |
| |
| |
|
| |
| |
|
| |
| |
ACCRUAL OF STOCK ISSUANCE COST |
65,000 | |
110,000 | |
( us-gaap:PaymentsOfStockIssuanceCosts ) |
| |
| |
|
(End Statement - Statements of Cash Flows (Unaudited)) |
|
Disclosure - Basis of FInancial Statement Presentation |
Disclosure - Basis of FInancial Statement Presentation (USD $) |
3 Months Ended |
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Basis of FInancial Statement Presentation |
| 1. | BASIS OF FINANCIAL STATEMENT PRESENTATION |
The accompanying unaudited condensedconsolidated financial statements have been prepared by ArtVentive Medical Group, Inc. the Company pursuant to therules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally includedin financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omittedin accordance with such rules and regulations. The information furnished in the interim condensed financial statements includesnormal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentationof such financial statements. Although management believes the disclosures and information presented are adequate to make the informationnot misleading, it is suggested that these interim condensed consolidated financial statements be read in conjunction with theCompany's audited financial statements and notes thereto included in its Form 10-K filed on March 31, 2015. Operating results forthe three months ended March 31, 2015 are not necessarily indicative of the results to be expected for the fiscal year ended December31, 2015. | |
( us-gaap:BasisOfAccounting ) |
| |
|
(End Disclosure - Basis of FInancial Statement Presentation) |
|
Disclosure - Organization |
Disclosure - Organization (USD $) |
3 Months Ended |
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Organization |
2. ORGANIZATION ArtVentive Medical Group, Inc. (theCompany), is a Nevada Corporation traded on the OTCQB (symbol AVTD). On January 9, 2010, the Company completed theacquisition of all of the assets of ArtVentive Medical Inc., a California company. The accounting and reporting policiesof the Company conform to accounting principles generally accepted in the United States of America, and the Companys fiscalyear end is December 31. The Company is a medical device corporation,focused on developing, manufacturing and marketing a family of Endoluminal Occlusion Devices (EOS TM). Through its innovative,proprietary technology the Company has developed unique minimally invasive occlusion devices and procedures, bringing the currentinterventional, image guided techniques to a new level of sophistication, potentially resolving significant and unaddressed healthissues. The EOS device being developed by the Company targets a substantive market demand in several major clinical areas, includingwomen's health, peripheral and neurological vascular disorders, and interventional cardiology procedures. To date, the Companys activitieshave been committed to the development of the EOSTM, intellectual property, animal studies, human studies, patent filings,manufacturing, sales, marketing and implementing its regulatory strategy for clinical indications pertinent to European and FDA Submissions and approvals, corporateoperations and the raising of equity capital. The Company conducted the requiredhuman clinical studies during 2011 achieving 100% clinical and procedural success, validating the safety and efficiency of theArtVentive EOSTM device. On August 3, 2011, the Company incorporatedArtVentive Womens Health Group, Inc., a wholly owned subsidiary of the Company. The Company received its CE Markcertification for the ArtVentive EOS Peripheral device on May 30, 2013, and implemented the planned EOS peripheraldevice transfer from Research and Development to commercialization, marketing, and distribution throughout Europe, simultaneousto making its FDA application. The Company received FDA approval for the ArtVentive EOS Peripheral device on December 3,2014. The Company filed additional patentapplications expanding its patent reach of the ArtVentive EOS device to 24 patents or patent applications. | |
( us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock ) |
| |
|
(End Disclosure - Organization) |
|
Disclosure - Significant Accounting Policies |
Disclosure - Significant Accounting Policies (USD $) |
3 Months Ended |
( AccountingPoliciesAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Significant Accounting Policies |
3. SIGNIFICANT ACCOUNTING POLICIES PRINCIPLES OF CONSOLIDATION The consolidated financial statements include the transactionsof the Company and its subsidiary. All inter-company accounts and transactions have beeneliminated in consolidation. USE OF ESTIMATES The preparation of the Companysfinancial statements in conformity with accounting principles generally accepted in the United States requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual resultscould differ from those estimates. The Companys periodic filings with the Securities and Exchange Commission include, whereapplicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and futureoperations of the Company. COMMON STOCK ISSUED FOR OTHER THAN CASH Services purchased and other transactionssettled in the Companys common stock and stock options are recorded at the estimated fair value of the stock issued andoptions granted if that value is more readily determinable than the fair value of the consideration received. EARNINGS PER SHARE OF COMMON STOCK In accordance with accounting guidancenow codified as FASB ASC Topic 260, Earnings per Share, basic earnings (loss) per share is computed by dividing netincome (loss) by weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per shareis computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents andpotentially dilutive securities outstanding during the period. The Company had the following potential common stock equivalentsat March 31, 2015: Common stock warrants 3,750,000 Common stock options 365,000 Convertible notes payable 515,835 Total common stock equivalents 4,630,835 Since the Company reflected a netloss as of March 31, 2015 and 2014, the effect of considering any common stock equivalents, if outstanding, would have been anti-dilutive.A separate computation of diluted earnings (loss) per share is not presented. The following table sets forth the computation of earningsper share: March 31, 2015 March 31, 2014 Net income (loss) $ (888,182) $ (1,756,492) Weighted average common shares outstanding 59,765,17556,022,953 Net (loss) per share $ (0.01) $ (0.03) PROPERTY AND EQUIPMENT The Company records property and equipment at cost anduses straight-line depreciation methods. | Estimated Useful Lives | March 31, 2015 | December 31, 2014 | Computer equipment Office furniture | 5 years 7 years | $ 16,147 4,746 | $ 13,207 4,746 | | | | | Less accumulated depreciation | | (6,397) | (5,467) | | | | | Net property and equipment | | $ 14,496 | $ 12,486 |
INVENTORY The Companys inventory isvalued at the lower of cost or market using the first-in, first-out (FIFO) method. As of March 31, 2015 and December 31, 2014,all inventory consisted of finished goods. As the Company begins its transitionfrom the Research and Development phase to production, management has estimated the cost of units sold to be equal to the revenuegenerated on those units. Other direct costs that may be associated with the production of these units has been reflected in Researchand Development expenses. FOREIGN CURRENCYTRANSLATIONS The Companys functionaland reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using theexchange rate prevailing on the date of transaction. Monetary assets and liabilitiesdenominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date.Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separatecomponent of stockholders equity (deficit) as a component of other comprehensive income or loss. Upon realization, the amountdeferred is recognized in income in the period when it is realized. CASH AND CASH EQUIVALENTS Cash and cash equivalents consistprincipally of funds on hand, deposit with banks and liquid investment funds having maturity of three months or less at the timeof the purchase. The Company has no cash equivalents. The Company had funds on deposit of $80,480 at March 31, 2015. REVENUE RECOGNITION Revenue for the sale of goods inthe course of the ordinary activities is measured at the fair value of the consideration received or receivable, net of returns.Revenue for sale of goods is recognized when the significant risks and rewards of ownership have been transferred to the buyer,recovery of the consideration is probable, the associated costs and possible return of the goods can be estimated reliably, thereis no continuing involvement with the goods, and the amount of the revenue can be measured reliably. CONCENTRATION OF RISK Certain financial instruments, whichsubject the Company to concentration of credit risk, consist of cash. The Company maintains cash balances at financial institutionswhich, from time to time, may exceed Federal Deposit Insurance Corporation insured limits of $250,000. As of March 31, 2015 andDecember 31, 2014, the Company had no deposits in excess of federally insured limits in its US bank. The Company has not experiencedany losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts. | |
( us-gaap:SignificantAccountingPoliciesTextBlock ) |
| |
|
(End Disclosure - Significant Accounting Policies) |
|
Disclosure - Note Payable |
Disclosure - Note Payable (USD $) |
3 Months Ended |
( DebtDisclosureAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Note Payable |
4. NOTE PAYABLE On April 1, 2014, the Company borrowed $250,000 from an unrelatedparty and issued a note payable on or before December 31, 2014, with interest at 3% per annum. On December 31, 2014, the Companyand the lender executed an extension of the note, which is now due on or before December 31, 2017. The interest remains at 3%.The lender may convert all or part of the debt, including interest, into common stock of the Company at any time at the rate of$1 per share. On April 1, 2014, the Company borrowed $250,000 from an unrelatedparty and issued a note payable on or before December 31, 2014, with interest at 3% per annum. On December 31, 2014, the Companyand the lender executed an extension of the note, which is now due on or before December 31, 2017. The interest remains at 3%.The lender may convert all or part of the debt, including interest, into common stock of the Company at any time at the rate of$1 per share. | March 31, 2015 | December 31, 2014 | Note payable to private party, with interest at 3.0%, with the balance, interest and principal, due December 31, 2017 | $ 250,000 | $ 250,000 | Note payable to private party, with interest at 3.0%, with the balance, interest and principal, due December 31, 2017 | 250,000 | 250,000 | Total | 500,000 | 500,000 | Less current maturities of long-term debt | - | - | Noncurrent maturities of long-term debt | $ 500,000 | $ 500,000 |
Maturities on long-term debt are as follows: 2015 | $ - | 2016 | - | 2017 | $ 500,000 | | $ 500,000 |
| |
( us-gaap:DebtDisclosureTextBlock ) |
| |
|
(End Disclosure - Note Payable) |
|
Disclosure - Share Capital |
Disclosure - Share Capital (USD $) |
3 Months Ended |
( EquityAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Share Capital |
5. SHARE CAPITAL Effective January 7, 2014, 400,000shares were issued in a private placement for the receipt of $400,000. Effective February 11, 2014,400,000 shares were issued in a private placement for the receipt of $400,000. Effective March 6, 2014, 300,000shares were issued in a private placement for the receipt of $300,000. Effective May 23, 2014, 100,000 shares wereissued in a private placement for the receipt of $100,000. Effective June 24, 2014, 1,000,000 shareswere issued in a private placement for the receipt of $1,000,000. Effective July 23, 2014, 500,000 shares wereissued in a private placement for the receipt of $500,000. Effective August 29, 2014, 250,000 shareswere issued in a private placement for the receipt of $250,000. Effective September 29, 2014, 150,000 shareswere issued in a private placement for the receipt of $150,000. Effective September 30, 2014, 100,000 shareswere issued in a private placement for the receipt of $100,000. Effective October 15, 2014, 100,000 shareswere issued in a private placement for the receipt of $100,000 Effective November 7, 2014, 80,000 shareswere issued in a private placement for the receipt of $80,000. Effective November 28, 2014, 70,000 shareswere issued in a private placement for the receipt of $70,000. Effective December 4, 2014, 250,000 shareswere issued in a private placement for the receipt of $250,000. Effective December 15, 2014, 250,000 shareswere issued in a private placement for the receipt of $250,000 Effective December 29, 2014, 250,000 shareswere issued in a private placement for the receipt of $250,000 Effective January 23, 2015, 250,000 shareswere issued in a private placement for the receipt of $250,000. Effective February 27, 2015, 150,000 shareswere issued in a private placement for the receipt of $250,000 Effective March 15, 2015, 100,000 shares wereissued in a private placement for the receipt of $100,000 Effective March 31, 2015, 150,000 shares wereissued in a private placement for the receipt of $150,000 | |
( us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock ) |
| |
|
(End Disclosure - Share Capital) |
|
Disclosure - Going Concern and Liquidity Considerations |
Disclosure - Going Concern and Liquidity Considerations (USD $) |
3 Months Ended |
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Going Concern and Liquidity Considerations |
7. recentlyissued accounting pronouncements Accounting Standards Updates(ASU) ASU No. 2015-07 which contain technical corrections to existing guidance or affect guidance to specializedindustries or entities were recently issued. These updates have no current applicability to the Company or their effect on thefinancial statements would not have been significant. | |
( us-gaap:LiquidityDisclosureTextBlock ) |
| |
|
(End Disclosure - Going Concern and Liquidity Considerations) |
|
Disclosure - Recently Issued Accounting Pronouncements |
Disclosure - Recently Issued Accounting Pronouncements (USD $) |
3 Months Ended |
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Recently Issued Accounting Pronouncements |
8. provisionfor income taxes The Company recognizes the taxeffects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reportedfor tax purposes. Deferred taxes are provided in the financial statements under ASC Topic 740 to give effect to the resulting temporarydifferences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costsbased on the income taxes expected to be payable in future years. Minimal exploration stage deferred tax assets arising as a resultof net operating loss carry forwards have been offset completely by a valuation allowance due to the uncertainty of their utilizationin future periods. The Company adopted the provisions of ASC Topic 740 Accounting for Uncertainty in Income Taxes, on January23, 2007 (inception date). As a result of the implementation of ASC 740, the Company recognized no increase in the liability forunrecognized tax benefits. Operating loss carry-forwards generatedduring the period of January 23, 2007 (date of inception), through March 31, 2015, of approximately $15.3 million, will begin toexpire in 2027. Accordingly, deferred tax assets of approximately $6.4 million related to net operating loss carry-forwards, andapproximately $150,000 related to stock-based compensation were offset by the valuation allowance in the same amount. For the threemonths ended March 31, 2015 and 2014, the allowance increased by approximately $370,000 and $750,000, respectively. The Company adopted the provisionsof FASB Interpretation No. 48 Accounting for Uncertainty in Income Taxes, on January 23, 2007. As a result of the implementationof Interpretation 48, the Company recognized no increase in the liability for unrecognized tax benefits. The Company has no tax positionsat March 31, 2015, or December 31, 2014, for which the ultimate deductibility is highly certain but for which there is uncertaintyabout the timing of such deductibility. The Companys tax returnsfor the years ended December 31, 2014, 2013, 2012 and 2011 are open for examination under Federal Statute of Limitations and forthe years ended December 31, 2014, 2013 and 2012 under the State of California Statute of Limitations. The Company recognizes interestaccrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company had no accrualsfor interest and penalties since inception. Components of income tax benefitsare as follows: Years Ended December 31, | 2014 | 2013 | $ - | $ - | - | - | - | - | - | - | - | - |
| |
( us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock ) |
| |
|
(End Disclosure - Recently Issued Accounting Pronouncements) |
|
Disclosure - Warrants and Options |
Disclosure - Warrants and Options (USD $) |
3 Months Ended |
( TemporaryEquityDisclosureAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Warrants and Options |
9. Warrantsand options Warrants: During the fiscal year ended December31, 2014, the Company granted 4,200,000 warrants to purchase shares of Common Stock which all have a 1 year exercise term, of which3,100,000 remain outstanding at March 31, 2015. During the quarter ended March 31, 2015, 650,000 warrants were issued. The Companyvalued all warrants utilizing a Black-Scholes option pricing model and the fair value was recorded in additional paid-in capital. The following is a summary of theCompanys warrant activity: | | Warrants | | Weighted Average Exercise Price | Exercisable December 31, 2013 | | 4,358,000 | | $ 1.50 | Granted-2014 | | 4,200,000 | | 1.50 | Exercised-2014 | | - | | - | Forfeited-2014 | | (4,358,000) | | - | Outstanding December 31, 2014 | | 4,200,000 | | $ 1.50 | Exercisable December 31, 2014 | | 4,200,000 | | $ 1.50 | | | | | | | | Warrants | | Weighted Average Exercise Price | Granted-2015 (at March 31, 2015) | | 650,000 | | $ 1.50 | Exercised-2015 (at March 31,2015) | | - | | - | Forfeited-2015 (at March 31, 2015) | | (1,100,000) | | $ 1.50 | Outstanding March 31, 2015 | | 3,750,000 | | $ 1.50 | Exercisable March 31, 2015 | | 3,750,000 | | $ 1.50 |
Warrants outstanding and exercisableat March 31, 2015 are as follows: Warrants Outstanding | | Warrants Exercisable | | Range of Exercise Price | | Number Outstanding | | Weighted Average Remaining Contractual Life (in Years) | | Weighted Average Exercise Price | | | Number Exercisable | | | Weighted Average Exercise Price | | $ | 1.50 | | 100,000 | | 0.14 years | | $ | 1.50 | | | | 100,000 | | | $ | 1.50 | | $ | 1.50 | | 1,000,000 | | 0.23 years | | $ | 1.50 | | | | 1,000,000 | | | $ | 1.50 | | $ | 1.50 | | 500,000 | | 0.31 years | | $ | 1.50 | | | | 500,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.40 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 150,000 | | 0.46 years | | $ | 1.50 | | | | 150,000 | | | $ | 1.50 | | $ | 1.50 | | 100,000 | | 0.50 years | | $ | 1.50 | | | | 100,000 | | | $ | 1.50 | | $ | 1.50 | | 100,000 | | 0.54 years | | $ | 1.50 | | | | 100,000 | | | $ | 1.50 | | $ | 1.50 | | 80,000 | | 0.61 years | | $ | 1.50 | | | | 80,000 | | | $ | 1.50 | | $ | 1.50 | | 70,000 | | 0.66 years | | $ | 1.50 | | | | 70,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.67 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.71 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.75 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.78 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 150,000 | | 0.91 years | | $ | 1.50 | | | | 150,000 | | | $ | 1.50 | | $ | 1.50 | | 100,000 | | 0.96 years | | $ | 1.50 | | | | 100,000 | | | $ | 1.50 | | $ | 1.50 | | 150,000 | | 1.00 years | | $ | 1.50 | | | | 150,000 | | | $ | 1.50 | |
Warrant activity is as follows: Effective May 23 2014, 100,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective June 24, 2014, 1,000,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective July 23 2014, 500,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective August 29 2014, 250,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective September 29, 20144,150,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vestingperiod, and the warrants expire in 1 year Effective September 30, 2013, 100,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective October 15 2014, 100,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective November 7, 2014, 80,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective November 28, 2014, 70,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective December 4, 2014, 250,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective December 15, 2014, 250,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective January 3, 2015, 250,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective January 23, 2015, 250,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective January 30, 2015, 150,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective March 15, 2015, 100,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Effective March 31, 2015, 150,000warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year Stock Options: During the period that the optionswere issued, the Company had no public trading activity for the Companys common stock. However, the majority shareholdersold in private transactions shares at $.90 per share. In order to value the Companys options, the Company chose to usethe minimum value method, even though the Company is a public company since there was no measurable trading activity. The fairvalue of the options was recorded in additional paid-in capital. Options outstanding and exercisableat March 31, 2015 are as follows: | | Options | | Weighted Average Exercise Price | Outstanding December 31, 2013 | | 305,000 | | $ 0.836 | Exercisable December 31, 2013 | | 105,000 | | $ 0.524 | Granted-2014 | | - | | $ - | Exercised-2014 | | - | | - | Forfeited-2014 | | - | | - | Outstanding December 31, 2014 | | 305,000 | | $ 0.836 | Exercisable December 31, 2014 | | 155,000 | | $ 0.678 | | | Options | | Weighted Average Exercise Price | Granted-2015 (at March 31, 2015) | | 60,000 | | $ - | Exercised-2014 (at March 31, 2015) | | - | | - | Forfeited-2014 (at March 31, 2015) | | - | | $ - | Outstanding March 31, 2015 | | 365,000 | | $ 0.863 | Exercisable March 31, 2015 | | 215,000 | | $ 0.767 |
Options outstandingand exercisable at March 31, 2015 are as follows: Options Outstanding | | Options Exercisable | | | Range of Exercise Price | | Number Outstanding | | Weighted Average Remaining Contractual Life (in Years) | | Weighted Average Exercise Price | | | Number Exercisable | | | Weighted Average Exercise Price | | $ | 0.001 | | 50,000 | | 1.59 years | | $ | 0.001 | | | | 50,000 | | | $ | 0.001 | | $ | 1.000 | | 35,000 | | 2.84 years | | $ | 1.000 | | | | 35,000 | | | $ | 1.000 | $ | 1.000 | | 10,000 | | 2.92 years | | $ | 1.000 | | | | 10,000 | | | $ | 1.000 | $ | 1.000 | | 200,000 | | 8.67 years | | $ | 1.000 | | | | 50,000 | | | $ | 1.000 | $ | 1.00 | | 10,000 | | 3.74 years | | $ | 1.000 | | | | 10,000 | | | $ | 1.000 | $ | 1.00 | | 50,000 | | 9.76 years | | $ | 1.000 | | | | 50,000 | | | $ | 1.000 | $ | 1.00 | | 10,000 | | 9.82 years | | $ | 1.000 | | | | 10,000 | | | $ | 1.000 | | | | | | | | | | | | | | | | | | | | | | | | | |
Stock option activity is asfollows: Effective November 2, 2010 theBoard of Directors of the Company granted 50,000 non-statutory stock options to a former consultant at an exercise price of $.001per share with the vesting date of November 2, 2013 and an expiration date of November 2, 2016. Effective February 1, 2013 theBoard of Directors of the Company granted 20,000 non-statutory stock options to a current consultant at an exercise price of $1.00per share with the vesting date of February 1, 2013 and an expiration date of February 1, 2018. Effective February 1, 2013 theBoard of Directors of the Company granted 5,000 non-statutory stock options to a current consultant at an exercise price of $1.00per share with the vesting date of February 1 2013 and an expiration date of February 1, 2018. Effective February 1, 2013 theBoard of Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00per share with the vesting date of February 1 2013 and an expiration date of February 1, 2018. Effective March 1, 2013 the Boardof Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00 pershare with the vesting date of March 1, 2013 and an expiration date of March 1, 2018. Effective December 27, 2013 theBoard of Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00per share with the vesting date of December 27, 2013 and an expiration date of December 27, 2018. Effective January 1, 2015 theBoard of Directors of the Company granted 50,000 non-statutory incentive stock options to a current employee at an exercise priceof $1.00 per share with 25% of the shares vested on January 1, 2016 and an additional 25% of shares exercisable on each of thenext succeeding three anniversaries of January 1, with the full portion exercisable on and after January 1, 2019. These shareshave an expiration date of January 1, 2025. Effective January 23, 2015 the Board of Directorsof the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00 per share withthe vesting date of January 23, 2015 and an expiration date of January 23, 2025. | |
( us-gaap:TemporaryEquityTableTextBlock ) |
| |
|
(End Disclosure - Warrants and Options) |
|
Disclosure - Subsequent Events |
Disclosure - Subsequent Events (USD $) |
3 Months Ended |
( SubsequentEventsAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Subsequent Events |
10.SUBSEQUENT EVENTS The Company evaluated all eventsor transactions that occurred after March 31, 2015, up through the date these consolidated financial statements were issued. Effective April 24, 2015, 150,000 shares wereissued in a private placement for the receipt of $150,000 Effective May 5, 2015, 100,000 shares wereissued in a private placement for the receipt of $100,000 | |
( us-gaap:SubsequentEventsTextBlock ) |
| |
|
(End Disclosure - Subsequent Events) |
|
Disclosure - Significant Accounting Policies (Policies) |
Disclosure - Significant Accounting Policies (Policies) (USD $) |
3 Months Ended |
( AccountingPoliciesAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Principles of Consolidation |
PRINCIPLES OF CONSOLIDATION The consolidated financial statements include the transactionsof the Company and its subsidiary. All inter-company accounts and transactions have beeneliminated in consolidation. | |
( us-gaap:ConsolidationPolicyTextBlock ) |
| |
USE OF ESTIMATES |
USE OF ESTIMATES The preparation of the Companysfinancial statements in conformity with accounting principles generally accepted in the United States requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual resultscould differ from those estimates. The Companys periodic filings with the Securities and Exchange Commission include, whereapplicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and futureoperations of the Company. | |
( us-gaap:UseOfEstimates ) |
| |
COMMON STOCK ISSUED FOR OTHER THAN CASH |
COMMON STOCK ISSUED FOR OTHER THAN CASH Services purchased and other transactionssettled in the Companys common stock and stock options are recorded at the estimated fair value of the stock issued andoptions granted if that value is more readily determinable than the fair value of the consideration received. | |
( us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock ) |
| |
EARNINGS PER SHARE OF COMMON STOCK |
EARNINGS PER SHARE OF COMMON STOCK In accordance with accounting guidancenow codified as FASB ASC Topic 260, Earnings per Share, basic earnings (loss) per share is computed by dividing netincome (loss) by weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per shareis computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents andpotentially dilutive securities outstanding during the period. The Company had the following potential common stock equivalentsat March 31, 2015: Common stock warrants 3,750,000 Common stock options 365,000 Convertible notes payable 515,835 Total common stock equivalents 4,630,835 Since the Company reflected a netloss as of March 31, 2015 and 2014, the effect of considering any common stock equivalents, if outstanding, would have been anti-dilutive.A separate computation of diluted earnings (loss) per share is not presented. The following table sets forth the computation of earningsper share: March 31, 2015 March 31, 2014 Net income (loss) $ (888,182) $ (1,756,492) Weighted average common shares outstanding 59,765,17556,022,953 Net (loss) per share $ (0.01) $ (0.03) | |
( us-gaap:EarningsPerSharePolicyTextBlock ) |
| |
Property Plant and Equipment Policy |
PROPERTY AND EQUIPMENT The Company records property and equipment at cost anduses straight-line depreciation methods. | Estimated Useful Lives | March 31, 2015 | December 31, 2014 | Computer equipment Office furniture | 5 years 7 years | $ 16,147 4,746 | $ 13,207 4,746 | | | | | Less accumulated depreciation | | (6,397) | (5,467) | | | | | Net property and equipment | | $ 14,496 | $ 12,486 |
| |
( us-gaap:PropertyPlantAndEquipmentPolicyTextBlock ) |
| |
INVENTORY |
INVENTORY The Companys inventory isvalued at the lower of cost or market using the first-in, first-out (FIFO) method. As of March 31, 2015 and December 31, 2014,all inventory consisted of finished goods. As the Company begins its transitionfrom the Research and Development phase to production, management has estimated the cost of units sold to be equal to the revenuegenerated on those units. Other direct costs that may be associated with the production of these units has been reflected in Researchand Development expenses. | |
( us-gaap:InventoryPolicyTextBlock ) |
| |
FOREIGN CURRENCY TRANSLATIONS |
FOREIGN CURRENCYTRANSLATIONS The Companys functionaland reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using theexchange rate prevailing on the date of transaction. Monetary assets and liabilitiesdenominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date.Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separatecomponent of stockholders equity (deficit) as a component of other comprehensive income or loss. Upon realization, the amountdeferred is recognized in income in the period when it is realized. | |
( us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock ) |
| |
CASH AND CASH EQUIVALENTS |
CASH AND CASH EQUIVALENTS Cash and cash equivalents consistprincipally of funds on hand, deposit with banks and liquid investment funds having maturity of three months or less at the timeof the purchase. The Company has no cash equivalents. The Company had funds on deposit of $80,480 at March 31, 2015. | |
( us-gaap:CashAndCashEquivalentsPolicyTextBlock ) |
| |
REVENUE RECOGNITION |
REVENUE RECOGNITION Revenue for the sale of goods inthe course of the ordinary activities is measured at the fair value of the consideration received or receivable, net of returns.Revenue for sale of goods is recognized when the significant risks and rewards of ownership have been transferred to the buyer,recovery of the consideration is probable, the associated costs and possible return of the goods can be estimated reliably, thereis no continuing involvement with the goods, and the amount of the revenue can be measured reliably. | |
( us-gaap:RevenueRecognitionPolicyTextBlock ) |
| |
CONCENTRATION OF RISK |
CONCENTRATION OF RISK Certain financial instruments, whichsubject the Company to concentration of credit risk, consist of cash. The Company maintains cash balances at financial institutionswhich, from time to time, may exceed Federal Deposit Insurance Corporation insured limits of $250,000. As of March 31, 2015 andDecember 31, 2014, the Company had no deposits in excess of federally insured limits in its US bank. The Company has not experiencedany losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts. | |
( us-gaap:ConcentrationRiskDisclosureTextBlock ) |
| |
|
(End Disclosure - Significant Accounting Policies (Policies)) |
|
Disclosure - Significant Accounting Policies (Tables) |
Disclosure - Significant Accounting Policies (Tables) (USD $) |
3 Months Ended |
( AccountingPoliciesAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Property and Equipment |
| Estimated Useful Lives | March 31, 2015 | December 31, 2014 | Computer equipment Office furniture | 5 years 7 years | $ 16,147 4,746 | $ 13,207 4,746 | | | | | Less accumulated depreciation | | (6,397) | (5,467) | | | | | Net property and equipment | | $ 14,496 | $ 12,486 |
| |
( us-gaap:PropertyPlantAndEquipmentScheduleOfSignificantAcquisitionsAndDisposalsTextBlock ) |
| |
|
(End Disclosure - Significant Accounting Policies (Tables)) |
|
Disclosure - Note Payable (Tables) |
Disclosure - Note Payable (Tables) (USD $) |
3 Months Ended |
( DebtDisclosureAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Notes Payable |
| March 31, 2015 | December 31, 2014 | Note payable to private party, with interest at 3.0%, with the balance, interest and principal, due December 31, 2017 | $ 250,000 | $ 250,000 | Note payable to private party, with interest at 3.0%, with the balance, interest and principal, due December 31, 2017 | 250,000 | 250,000 | Total | 500,000 | 500,000 | Less current maturities of long-term debt | - | - | Noncurrent maturities of long-term debt | $ 500,000 | $ 500,000 |
| |
( us-gaap:ScheduleOfDebtTableTextBlock ) |
| |
|
(End Disclosure - Note Payable (Tables)) |
|
Disclosure - Recently Issued Accounting Pronouncements (Tables) |
Disclosure - Recently Issued Accounting Pronouncements (Tables) (USD $) |
3 Months Ended |
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Schedule of Income Tax Benefits |
Years Ended December 31, | 2014 | 2013 | $ - | $ - | - | - | - | - | - | - | - | - |
| |
( us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock ) |
| |
|
(End Disclosure - Recently Issued Accounting Pronouncements (Tables)) |
|
Disclosure - Warrants and Options (Tables) |
Disclosure - Warrants and Options (Tables) (USD $) |
3 Months Ended |
( TemporaryEquityDisclosureAbstract ) |
|
|
Mar. 31, 2015 |
|
|
|
|
|
|
Schedule of Warrants |
| | Warrants | | Weighted Average Exercise Price | Exercisable December 31, 2013 | | 4,358,000 | | $ 1.50 | Granted-2014 | | 4,200,000 | | 1.50 | Exercised-2014 | | - | | - | Forfeited-2014 | | (4,358,000) | | - | Outstanding December 31, 2014 | | 4,200,000 | | $ 1.50 | Exercisable December 31, 2014 | | 4,200,000 | | $ 1.50 | | | | | | | | Warrants | | Weighted Average Exercise Price | Granted-2015 (at March 31, 2015) | | 650,000 | | $ 1.50 | Exercised-2015 (at March 31,2015) | | - | | - | Forfeited-2015 (at March 31, 2015) | | (1,100,000) | | $ 1.50 | Outstanding March 31, 2015 | | 3,750,000 | | $ 1.50 | Exercisable March 31, 2015 | | 3,750,000 | | $ 1.50 |
| |
( us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock ) |
| |
Warrants outstanding and exercisable |
Warrants Outstanding | | Warrants Exercisable | | Range of Exercise Price | | Number Outstanding | | Weighted Average Remaining Contractual Life (in Years) | | Weighted Average Exercise Price | | | Number Exercisable | | | Weighted Average Exercise Price | | $ | 1.50 | | 100,000 | | 0.14 years | | $ | 1.50 | | | | 100,000 | | | $ | 1.50 | | $ | 1.50 | | 1,000,000 | | 0.23 years | | $ | 1.50 | | | | 1,000,000 | | | $ | 1.50 | | $ | 1.50 | | 500,000 | | 0.31 years | | $ | 1.50 | | | | 500,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.40 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 150,000 | | 0.46 years | | $ | 1.50 | | | | 150,000 | | | $ | 1.50 | | $ | 1.50 | | 100,000 | | 0.50 years | | $ | 1.50 | | | | 100,000 | | | $ | 1.50 | | $ | 1.50 | | 100,000 | | 0.54 years | | $ | 1.50 | | | | 100,000 | | | $ | 1.50 | | $ | 1.50 | | 80,000 | | 0.61 years | | $ | 1.50 | | | | 80,000 | | | $ | 1.50 | | $ | 1.50 | | 70,000 | | 0.66 years | | $ | 1.50 | | | | 70,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.67 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.71 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.75 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 250,000 | | 0.78 years | | $ | 1.50 | | | | 250,000 | | | $ | 1.50 | | $ | 1.50 | | 150,000 | | 0.91 years | | $ | 1.50 | | | | 150,000 | | | $ | 1.50 | | $ | 1.50 | | 100,000 | | 0.96 years | | $ | 1.50 | | | | 100,000 | | | $ | 1.50 | | $ | 1.50 | | 150,000 | | 1.00 years | | $ | 1.50 | | | | 150,000 | | | $ | 1.50 | |
| |
( us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock ) |
| |
Options Outstanding and Exercisable |
| | Options | | Weighted Average Exercise Price | Outstanding December 31, 2013 | | 305,000 | | $ 0.836 | Exercisable December 31, 2013 | | 105,000 | | $ 0.524 | Granted-2014 | | - | | $ - | Exercised-2014 | | - | | - | Forfeited-2014 | | - | | - | Outstanding December 31, 2014 | | 305,000 | | $ 0.836 | Exercisable December 31, 2014 | | 155,000 | | $ 0.678 | | | Options | | Weighted Average Exercise Price | Granted-2015 (at March 31, 2015) | | 60,000 | | $ - | Exercised-2014 (at March 31, 2015) | | - | | - | Forfeited-2014 (at March 31, 2015) | | - | | $ - | Outstanding March 31, 2015 | | 365,000 | | $ 0.863 | Exercisable March 31, 2015 | | 215,000 | | $ 0.767 |
| |
( us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock ) |
| |
Options outstanding and exercisable |
Options Outstanding | | Options Exercisable | | | Range of Exercise Price | | Number Outstanding | | Weighted Average Remaining Contractual Life (in Years) | | Weighted Average Exercise Price | | | Number Exercisable | | | Weighted Average Exercise Price | | $ | 0.001 | | 50,000 | | 1.59 years | | $ | 0.001 | | | | 50,000 | | | $ | 0.001 | | $ | 1.000 | | 35,000 | | 2.84 years | | $ | 1.000 | | | | 35,000 | | | $ | 1.000 | $ | 1.000 | | 10,000 | | 2.92 years | | $ | 1.000 | | | | 10,000 | | | $ | 1.000 | $ | 1.000 | | 200,000 | | 8.67 years | | $ | 1.000 | | | | 50,000 | | | $ | 1.000 | $ | 1.00 | | 10,000 | | 3.74 years | | $ | 1.000 | | | | 10,000 | | | $ | 1.000 | $ | 1.00 | | 50,000 | | 9.76 years | | $ | 1.000 | | | | 50,000 | | | $ | 1.000 | $ | 1.00 | | 10,000 | | 9.82 years | | $ | 1.000 | | | | 10,000 | | | $ | 1.000 | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
( us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock ) |
| |
|
(End Disclosure - Warrants and Options (Tables)) |
|
Disclosure - Significant Accounting Policies - Property and Equipment (Details) |
Disclosure - Significant Accounting Policies - Property and Equipment (Details) (USD $) |
|
|
( AccountingPoliciesAbstract ) |
|
|
|
Mar. 31, 2015 |
Dec. 31, 2014 |
|
|
|
|
|
|
|
|
|
Computer equipment Office furniture |
161,474,746 | |
132,074,746 | |
( us-gaap:MachineryAndEquipmentGross ) |
| |
| |
|
| |
| |
|
| |
| |
Less accumulated depreciation |
(6,397 | ) |
(5,467 | ) |
( us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets ) |
| |
| |
|
| |
| |
|
| |
| |
Net property and equipment |
14,496 | |
12,486 | |
( us-gaap:PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets ) |
| |
| |
|
(End Disclosure - Significant Accounting Policies - Property and Equipment (Details)) |
|
Disclosure - Significant Accounting Policies (Details Narrative) |
Disclosure - Significant Accounting Policies (Details Narrative) (USD $) |
|
( AccountingPoliciesAbstract ) |
|
|
|
|
|
|
|
|
|
Common Stock Warrants |
3,750,000 | |
( us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants ) |
| |
|
(End Disclosure - Significant Accounting Policies (Details Narrative)) |
|
Disclosure - Subsequent Events (Details Narrative) |
Disclosure - Subsequent Events (Details Narrative) (USD $) |
|
( SubsequentEventsAbstract ) |
|
|
|
|
|
|
|
|
|
Private Placement |
150,000 | |
( us-gaap:StockIssuedDuringPeriodSharesOther ) |
| |
Proceeds from stock sale |
$150,000 | |
( us-gaap:ProceedsFromIssuanceOfCommonStock ) |
| |
|
(End Disclosure - Subsequent Events (Details Narrative)) |
Contexts |
ID |
Period |
CIK |
Dimensions |
From2015-01-01to2015-03-31 |
2015-01-01 - 2015-03-31 |
0001405249 |
|
AsOf2015-05-12 |
2015-05-12 |
0001405249 |
|
AsOf2015-03-31 |
2015-03-31 |
0001405249 |
|
AsOf2014-12-31 |
2014-12-31 |
0001405249 |
|
From2014-01-01to2014-03-31 |
2014-01-01 - 2014-03-31 |
0001405249 |
|
AsOf2013-12-31 |
2013-12-31 |
0001405249 |
|
AsOf2014-03-31 |
2014-03-31 |
0001405249 |
|
|
(End Contexts) |
|
Elements |
|
|
|
|
|
|
|
|
|
Element |
Data Type |
Period Type |
Balance Type |
Custom |
AccountingPoliciesAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
DebtDisclosureAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
EquityAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
SubsequentEventsAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
TemporaryEquityDisclosureAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
custom:DocumentAndEntityInformationAbstract |
xbrli:stringItemType |
| Duration |
| |
| Yes (Auto) |
|
|
|
dei:AmendmentFlag |
xbrli:booleanItemType |
| Duration |
| |
| |
|
If the value is true, then the document is an amendment to previously-filed/accepted document. |
|
dei:CurrentFiscalYearEndDate |
xbrli:gMonthDayItemType |
| Duration |
| |
| |
|
End date of current fiscal year in the format --MM-DD. |
|
dei:DocumentFiscalPeriodFocus |
dei:fiscalPeriodItemType |
| Duration |
| |
| |
|
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY. |
|
dei:DocumentFiscalYearFocus |
xbrli:gYearItemType |
| Duration |
| |
| |
|
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006. |
|
dei:DocumentPeriodEndDate |
xbrli:dateItemType |
| Duration |
| |
| |
|
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD. |
|
dei:DocumentType |
dei:submissionTypeItemType |
| Duration |
| |
| |
|
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other". |
|
dei:EntityCentralIndexKey |
dei:centralIndexKeyItemType |
| Duration |
| |
| |
|
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. |
|
dei:EntityCommonStockSharesOutstanding |
xbrli:sharesItemType |
| Instant |
| |
| |
|
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. |
|
dei:EntityCurrentReportingStatus |
dei:yesNoItemType |
| Duration |
| |
| |
|
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure. |
|
dei:EntityFilerCategory |
dei:filerCategoryItemType |
| Duration |
| |
| |
|
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure. |
|
dei:EntityPublicFloat |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K. |
|
dei:EntityRegistrantName |
xbrli:normalizedStringItemType |
| Duration |
| |
| |
|
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. |
|
dei:EntityVoluntaryFilers |
dei:yesNoItemType |
| Duration |
| |
| |
|
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. |
|
dei:EntityWellKnownSeasonedIssuer |
dei:yesNoItemType |
| Duration |
| |
| |
|
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A. |
|
us-gaap:AccountsPayableCurrent |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
|
us-gaap:AccountsReceivableNet |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
For an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. |
|
us-gaap:AccruedLiabilitiesCurrent |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
|
us-gaap:AccruedLiabilitiesCurrentAndNoncurrent |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. |
|
us-gaap:AccruedPayrollTaxesCurrent |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
|
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. |
|
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land or leased assets). |
|
us-gaap:AdditionalPaidInCapital |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. |
|
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. |
|
us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:Assets |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
|
us-gaap:AssetsAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:AssetsCurrent |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
|
us-gaap:AssetsCurrentAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:BasisOfAccounting |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). |
|
us-gaap:Cash |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
|
us-gaap:CashAndCashEquivalentsAtCarryingValue |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
|
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. |
|
us-gaap:CashAndCashEquivalentsPolicyTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value. |
|
us-gaap:CommonStockParOrStatedValuePerShare |
num:perShareItemType |
| Instant |
| |
| |
|
Face amount or stated value per share of common stock. |
|
us-gaap:CommonStockSharesAuthorized |
xbrli:sharesItemType |
| Instant |
| |
| |
|
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. |
|
us-gaap:CommonStockSharesIssued |
xbrli:sharesItemType |
| Instant |
| |
| |
|
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. |
|
us-gaap:ComprehensiveIncomeNetOfTax |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
|
us-gaap:ConcentrationRiskDisclosureTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. |
|
us-gaap:ConsolidationPolicyTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary. |
|
us-gaap:CostOfGoodsSold |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
Total costs related to goods produced and sold during the reporting period. |
|
us-gaap:DebtDisclosureTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. |
|
us-gaap:Deposits |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others. |
|
us-gaap:Depreciation |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
|
us-gaap:DepreciationAndAmortization |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
|
us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate. |
|
us-gaap:EarningsPerSharePolicyTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements. |
|
us-gaap:EquityAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:ExplorationCosts |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The capitalized costs incurred during the period (excluded from amortization) in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&G" costs. Exploration costs also include costs o |
|
us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy. |
|
us-gaap:GrossProfit |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
|
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare |
num:perShareItemType |
| Duration |
| |
| |
|
The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. |
|
us-gaap:IncomeStatementAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:IncomeTaxesPaid |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. |
|
us-gaap:IncreaseDecreaseInAccountsPayable |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
|
us-gaap:IncreaseDecreaseInAccountsReceivable |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
|
us-gaap:IncreaseDecreaseInAccruedLiabilities |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
|
us-gaap:IncreaseDecreaseInDeposits |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances. |
|
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. |
|
us-gaap:IncreaseDecreaseInInventories |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
|
us-gaap:IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:IncreaseDecreaseInPrepaidExpense |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. |
|
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants |
xbrli:sharesItemType |
| Duration |
| |
| |
|
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. |
|
us-gaap:InterestAndDividendIncomeOperating |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein. |
|
us-gaap:InventoryGross |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. |
|
us-gaap:InventoryPolicyTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory. |
|
us-gaap:LiabilitiesAndStockholdersEquity |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
|
us-gaap:LiabilitiesAndStockholdersEquityAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:LiabilitiesCurrent |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
|
us-gaap:LiabilitiesCurrentAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:LiquidityDisclosureTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substa |
|
us-gaap:LongTermDebtAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:LongTermDebtNoncurrent |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. |
|
us-gaap:MachineryAndEquipmentGross |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment. |
|
us-gaap:NetCashProvidedByUsedInContinuingOperations |
xbrli:monetaryItemType |
| Duration |
| |
| |
|
The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label. |
|
us-gaap:NetCashProvidedByUsedInFinancingActivities |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
|
us-gaap:NetCashProvidedByUsedInFinancingActivitiesAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:NetCashProvidedByUsedInInvestingActivities |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
|
us-gaap:NetCashProvidedByUsedInInvestingActivitiesAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:NetIncomeLoss |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
|
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). |
|
us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact. |
|
us-gaap:NoncashInvestingAndFinancingItemsAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:NotesPayable |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. |
|
us-gaap:OperatingExpenses |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
|
us-gaap:OperatingExpensesAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:OperatingIncomeLoss |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The net result for the period of deducting operating expenses from operating revenues. |
|
us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure. |
|
us-gaap:OtherAssets |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
The aggregate carrying amounts, as of the balance sheet date, of assets not separately disclosed in the balance sheet. |
|
us-gaap:OtherAssetsAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:OtherNoncashIncomeExpense |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed. |
|
us-gaap:OtherOperatingIncomeExpenseNet |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. |
|
us-gaap:PaymentsOfStockIssuanceCosts |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The cash outflow for cost incurred directly with the issuance of an equity security. |
|
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
|
us-gaap:PrepaidExpenseCurrent |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
|
us-gaap:ProceedsFromIssuanceOfCommonStock |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The cash inflow from the additional capital contribution to the entity. |
|
us-gaap:ProceedsFromIssuanceOrSaleOfEquity |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. |
|
us-gaap:ProceedsFromNotesPayable |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The cash inflow from a borrowing supported by a written promise to pay an obligation. |
|
us-gaap:PropertyPlantAndEquipmentAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:PropertyPlantAndEquipmentNet |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
|
us-gaap:PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets excluding assets held under lease agreements used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. |
|
us-gaap:PropertyPlantAndEquipmentOther |
xbrli:monetaryItemType |
| Instant |
| Debit |
| |
|
Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale. |
|
us-gaap:PropertyPlantAndEquipmentPolicyTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments. |
|
us-gaap:PropertyPlantAndEquipmentScheduleOfSignificantAcquisitionsAndDisposalsTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of all information related to any significant acquisition and disposal. Disclosure may include methodology and assumptions, type of asset, asset classification, useful life, useful purpose, acquisition cost, method of acquisition or disposal, depreciation method, gain (loss) on disposal pretax and net of tax, date of acquisition or disposal and restrictions on amount of proceeds from donated assets. |
|
us-gaap:RepaymentsOfRelatedPartyDebt |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. |
|
us-gaap:ResearchAndDevelopmentExpense |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. |
|
us-gaap:RetainedEarningsAccumulatedDeficit |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
The cumulative amount of the reporting entity's undistributed earnings or deficit. |
|
us-gaap:RevenueRecognitionPolicyTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction. |
|
us-gaap:Revenues |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
|
us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years. |
|
us-gaap:ScheduleOfDebtTableTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation. |
|
us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value. |
|
us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. |
|
us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. |
|
us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. |
|
us-gaap:SellingGeneralAndAdministrativeExpense |
xbrli:monetaryItemType |
| Duration |
| Debit |
| |
|
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
|
us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. |
|
us-gaap:SignificantAccountingPoliciesTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
The entire disclosure for all significant accounting policies of the reporting entity. |
|
us-gaap:StatementOfCashFlowsAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:StatementOfFinancialPositionAbstract |
xbrli:stringItemType |
| Duration |
| |
| |
|
|
|
us-gaap:StockIssuedDuringPeriodSharesOther |
xbrli:sharesItemType |
| Duration |
| |
| |
|
Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed. |
|
us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities |
xbrli:monetaryItemType |
| Duration |
| Credit |
| |
|
The gross value of stock issued during the period upon the conversion of convertible securities. |
|
us-gaap:StockholdersEquity |
xbrli:monetaryItemType |
| Instant |
| Credit |
| |
|
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. |
|
us-gaap:SubsequentEventsTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. |
|
us-gaap:TemporaryEquityTableTextBlock |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock wit |
|
us-gaap:UseOfEstimates |
nonnum:textBlockItemType |
| Duration |
| |
| |
|
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles. |
|
us-gaap:WeightedAverageBasicSharesOutstandingProForma |
xbrli:sharesItemType |
| Duration |
| |
| |
|
The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering. |
|
Total Elements |
|
134 |
Total Non-Abstract Elements |
|
109 |
Total Extension Elements |
|
1 |
Percent Extended |
|
0% |
Percent Extended (excluding abstracts) |
|
0% |
|
(End Elements) |